Valuable review recently published in the American Journal of Psychiatry on the clinical application of psychedelic drugs for mental health disorders. The review provides details of three psychedelic compounds: LSD, psilocybin, ayahuasca and MDMA. The findings indicate that the results of randomised controlled trials investigating psychedelic-assisted therapy support the efficacy of MDMA in the treatment of PTSD and psilocybin in the treatment of depression.

More information available here

Information on latest trial of MDMA-assisted therapy for PTSD available here

Photo of Harvard University by Su puloo on Unsplash